U.S. federal trademark · Serial No. 88482091
Exosomes from engineered autologous mesenchymal stem cells for the treatment of autoimmune disorders and cancer
Cell-derived therapy services involving use of exosomes for the treatment of autoimmune disorders and cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.